AMPIVIEW™ RNA probes are uniquely designed with the precision of targeted, sequence-specific RNA probes, powered by Enzo's LoopRNA ISH™ technology to deliver superior sensitivity. AMPIVIEW™ HPV 6/11 RNA probes is a mixture of digoxigenin-labeled probes targeting HPV type 6 and HPV type 11 for in situ hybridization. The probes are formulated in a buffered formamide solution with hybridization enhancers.
Normal cervical tissue shows no signal when detected with AMPIVIEW™ HPV 6/11 RNA Probes
Please mouse over
Product Details
Applications:
ISH (in situ hybridization)
Application Notes:
AMPIVIEW™ HPV 6/11 RNA probes have been designed to target the human papillomavirus (HPV) type 6 and type 11 for its detection in tissues and cells. AMPIVIEW™ HPV 6/11 RNA probes are conjugated with digoxigenin and have been optimized to produce clear results with Enzo's nanopolymer-based detection system, POLYVIEW® Plus, DIGX® anti-digoxigenin linker and, high-quality HIGHDEF®chromogens and counterstains to produce clear results that can be visualized with a light microscope.
Upon receipt, aliquot and store at -20ºC. For long-term storage, store at -80ºC. These products, under these conditions, are stable until the expiration date.
Handling:
Allow contents to reach room temperature prior to use.
Shipping:
Dry Ice
Short Term Storage:
-20°C
Long Term Storage:
-80°C
Technical Info/Product Notes:
AMPIVIEW™ HPV 6/11 RNA Probes are optimized for detection with either POLYVIEW® PLUS detection reagents, HIGHDEF® chromogens and counterstains (not inlcuded). Dilutions and concentration optimization can be done with AMPIVIEW™ hybridization buffer, included in this set.
Regulatory Status:
RUO - Research Use Only
General Literature References
Recent improvements in immunohistochemistry and in situ hybridization: G.J. Nuovo, et al.; In Situ Molecular Pathology and Co-Expression Analyses 2nd Edition, 213 (2020), Book Chapter,
Recent Improvements in In situ Hybridization for the Detection of HPV Infections in Clinical Samples: G. La Rocca, et al.; World Cancer Research Journal 7, 1-8 (2020), Full Text
